Search

everythinglearnresearchcommunity

for

Search:↓

Fetal wounds heal without scarring because of different biological factors, which could help improve adult wound healing.

Hair changes can indicate systemic diseases or medication effects.

Targeted cancer therapies have a significant but lower risk of causing hair loss compared to chemotherapy.

Blocking EGFR in skin cells doesn't majorly increase inflammation markers.

A new treatment called deucravacitinib helped a patient with severe hair loss grow their hair back quickly.

VEGF helps hair grow and determines follicle size by increasing blood vessel growth.

Cancer treatments targeting specific cells and the immune system can cause skin, mouth, hair, and nail problems, affecting patients' quality of life and treatment adherence.

The research found ways to activate melanocyte stem cells for potential treatment of skin depigmentation conditions.

Certain herbal compounds, especially from bitter melon, can inhibit cancer growth and promote hair growth by blocking PAK1.

Natural products show promise for new hair loss treatments.

Higher STAT3 levels are found in hair loss areas, but not linked to hair loss severity.

New mutations in the SLC39A4 gene found in twins help understand the genetic cause of acrodermatitis enteropathica.

Susan Lee Lindquist was a pioneering biologist who made significant contributions to understanding protein folding and its role in disease.

Hair greying is seen as a sign of aging; temporary fixes like hair dye are used, but a balanced diet and hair care can help manage it.

Tofacitinib citrate is effective for moderate-to-severe chronic plaque psoriasis but has safety concerns at higher doses.

Ruxolitinib may help treat hair loss by reducing inflammation, promoting hair growth signals, and protecting hair follicle immunity.

A new carrier improves skin delivery of tofacitinib for treating inflammatory skin diseases.

Cancer treatments targeting specific cells often cause skin, hair, and nail problems, affecting patients' lives and requiring careful management.

Cancer treatments can cause skin-related side effects that may affect patient quality of life and require changes in treatment.

Using CDK inhibitors on rats showed a reduction in chemotherapy-caused hair loss, but later experiments could not repeat these results.

Autophagy helps control skin inflammation and cancer responses and regulates hair growth by affecting stem cell activity.

New treatments for advanced skin cancer are improving patient outcomes, but drug resistance and finding the right treatment combinations are still big challenges.

Oral JAK inhibitors are effective and safe for treating alopecia areata but may need ongoing use to keep results.

Blue-light activation of TrkA improves hair-follicle stem cells' ability to become neurons and glial cells.

The protein folliculin, involved in a rare disease, works with another protein to control how cells stick together and their organization, and changes in this interaction can lead to disease symptoms.

Higher levels of certain DNAs in blood may indicate hair follicle damage in alopecia areata patients.

Planarian regeneration begins with a specific gene activation caused by injury, essential for healing and tissue regrowth.

TLR4 is important in aging-related diseases and could be a new treatment target.

New regenerative treatments for hair loss show promise but need more research for confirmation.

New treatments for COVID-19 show promise, but more effective antiviral drugs are needed.